secwatch / observer
8-K filed November 3, 2021, 7:59 PM ET ticker TVRD CIK 0001346830
leadership confidence high sentiment neutral materiality 0.65

Cara Therapeutics appoints Christopher Posner as President and CEO; Derek Chalmers transitions to Senior Advisor

Tvardi Therapeutics, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher Posner

President and CEO
TVRD · Tvardi Therapeutics, Inc.
Effective
2021-11-09
Filed
November 3, 2021, 7:59 PM ET
the appointment of Christopher Posner, age 52, a current non-employee director of the Company, to serve as President and CEO of the Company, effective November 9, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Posner was appointed as President and CEO at Tvardi Therapeutics, Inc..

Action
appointed
Role
President and CEO
Exact text from the filing
the appointment of Christopher Posner, age 52, a current non-employee director of the Company, to serve as President and CEO of the Company, effective November 9, 2021.
View on SEC.gov

Tvardi Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-21-133381
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.